The pressure fl ow relationship of the internal mammary artery after offpump anastomosis to the left anterior descending coronary artery 
INTRODUCTION
The internal mammary artery (IMA) is the most commonly used conduit graft for anastomosis to the left anterior descending (LAD) coronary artery, being used on average 80% of the time. (1) Offpump coronary artery bypass grafting (OPCAB) remains a commonly employed strategy for revascularisation with many reported benefi ts, (2, 3, 4) despite recent evidence to dispute this. (5) This study aimed to assess the changes in fl ow of the internal mammary artery relative to varying arterial blood pressures, directly after OPCAB grafting of the left internal mammary artery to the LAD. The pressure fl ow relationship was also assessed with the IMA in situ and after having skeletonising the artery.
We hypothesised that there may be a loss of autoregulation once the IMA was removed from the chest wall and after anastomosis
to the IMA. We tested this hypothesis using three different anaesthetic techniques, using halothane, propofol and sevofl urane.
For the purpose of this study, autoregulation refers to the perfusion pressure-coronary blood fl ow relationship and we did not attempt to incorporate the third variable of autoregulation i.e. work of the heart, into the study. pentobarbital (8mg/kg), thiopental (2 mg/kg) and fentanyl (16ug/kg).
A tracheostomy was performed after loss of eyelid refl ex, the trachea was intubated and the animals ventilated (Julian, Drager, Germany) with 50 % oxygen and air. The tidal volume was set at 10ml/kg and the PaCO2 maintained between 34-36mmHg.
Muscle relaxation was achieved with pancuronium bromide, using an initial bolus dose of 0.2mg/kg followed by a constant infusion of 0.3mg/kg/h.
Five of the pigs were randomly allocated to receive halothane for maintenance of anaesthesia at 0.7% expiratory concentration.
A further fi ve randomly assigned pigs received propofol as a constant intravenous infusion according to the Bristol protocol. (6) A three compartment pharmacokinetic computer model simulation using this protocol, predicted a blood level of 2.5-3.0ug/ml. This is similar to levels achieved in the clinical setting. The remaining fi ve pigs received sevofl urane at 2% expiratory concentration for maintenance of anaesthesia. 
Statistical methods used
Since different pressures were applied to the IMA to measure the % fl ow under different treatments given to the pigs, the internal mammary artery was considered to be the experimental unit. Linear regression models were fi tted with % fl ow as the response variable and % mean arterial pressure as the indepen-
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(r=0.8553), the skeletonised IMA (r=0.9391) and the grafted IMA (r=0.9129). There was no signifi cant difference in the gradients of the regression lines as depicted in Figure 3 . This suggests that there is no autoregulation of the IMA during halothane anaesthesia.
The propofol subgroup
The mean baseline MAP before positional manipulation in the dent or concomitant variable. A signifi cance level of alpha = 5% was used for the study. The comparison of the slopes of the lines were done with analysis of variance methods as published by Quinn and Keough.
RESULTS

The complete group
The mean baseline MAP for the group as a whole was 67mmHg.
The relationship between fl ow and pressure after grafting the IMA to the LAD was found to be linear (r=0.8766). Similarly the relationship between fl ow and pressure after skeletonising the IMA was found to be linear (r=0.8650). The pressure fl ow relationship of the in situ IMA was also found to be linear in nature (r=0.7863). This calculated regression line was numerically more horizontal than the skeletonised and anastomosed lines, but the gradients (slopes) of these lines did not differ signifi cantly (F= 2.395, p=0.093). This relationship is shown in Figure 1 .
The halothane subgroup
The mean baseline MAP before positional manipulation in this group was 57mmHg (range of baseline pressures 41mmHg to 80mmHg). The induced pressures and resulting fl ows generated for each pig are presented in Figure 2 . The observed relationships between pressure and fl ow were linear for the in situ IMA respectively). No signifi cant difference in the gradients of these regression lines was seen in this subgroup as seen in Figure 5 .
As with the halothane subgroup, this suggests that there is no autoregulation of the IMA during propofol anaesthesia.
The sevofl urane subgroup
The sevofl urane group had a mean baseline MAP of 68mmHg
(range of baseline pressures 29mmHg to 102mmHg). The induced pressures and resulting fl ows generated for each pig for the sevofl urane group, are presented in Figure 6 . The in situ IMA which are normally released by these nerve endings. (10, 11) The lack of these mediators may result in a decrease in the autoregulatory potential of the IMA to vasoconstrict, as the normal balance with vasodilators such as nitric oxide (NO), prostacyclin and endothelium-derived hyperpolarising factor is disturbed. (12, 13) There is also evidence that skeletonising the IMA may lead to dysfunctional or denuded arterial endothelium. (14) NO, normally synthesised in the endothelial layer, is known to be largely responsible for arterial conduit vasodilation in response to an increase in blood fl ow. Dysfunctional endothelium, which can arise from skeletonising the IMA, may thus lead to a decrease in the autoregulatory capacity of the artery to vasodilate. The relationships of these vasoactive agents are complex and the relative contribution of each agent under varying conditions is not known.
Sevofl urane causes relaxation of vascular smooth muscle in a concentration dependant manor, mainly through a decrease in the intracellular calcium concentration. (16) This has been experimentally shown to occur via a direct inhibition of calcium release from the sarcoplasmic reticulum or sarcolemmal calcium stores. (17) Evidence also exists that sevofl urane decreases the sensitising of contractile proteins by calcium, however the exact mechanism is not fully understood. (18) In addition sevofl urane inhibits the second messenger IP3 which is responsible for calcium release intracellularly. (19) It does this to a lesser extent than either halothane or propofol. Sevofl urane may thus potentially inhibit autoregulatory vasoconstriction by decreasing the vascular tone of the in situ IMA, and this may well explain the absence of normal autoregulation in the IMA as shown by our results.
Halothane like sevofl urane inhibits intracellular calcium concentration as well as contractile apparatus sensitivity. (20) The effect of lowering intracellular calcium is more evident at lower concentrations, and the desensitising of contractile elements more pronounced at higher concentrations of the agent. (20) Convincing evidence exists that the decrease of intracellular calcium concentration is through inhibition of release from the sarcoplasmic stores. (21) Halothane is also known to inhibit the L-type calcium release channels, thereby decreasing plasmalemmal calcium infl ux, further contributing to decrease in contractile ability. (22) Halothane, unlike sevofl urane has however been shown to cause ryanodine receptor mediated release of calcium from intracellular stores. (23) This facilitates a transient smooth muscle cell contraction via
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DISCUSSION
We have demonstrated that in a porcine model, the fl ow of blood through the IMA is directly dependent on the arterial pressure. Propofol has been shown to increase basal vascular tone at clinical and low concentrations, but decrease basal tone in arteries at high concentrations. (24, 25) This increase in basal tone seems to be endothelium independent, and is thought to be via activation of voltage dependant calcium channels. (26) Propofol has also been shown to directly inhibit calcium release from the sarcoplasmic reticulum, as well as decreasing inositol phosphate production. (27, 28) This results in a decrease in vascular tone, how- properties. (29, 30) However, unlike in patients with normal coronary arteries, patients post CABG cannot rely on autoregulatory mechanisms to maintain their coronary fl ow. Once the blood pressure falls, either the ventricle becomes ischaemic, leading to ischaemic paralysis of the myocardium, or hibernation of the myocardium occurs, resulting in a decrease in myocardial work. (31, 32) Both mechanisms result in a decrease in cardiac output, and a negative spiral of falling blood pressures and poor cardiac output commences. A decrease in coronary fl ow is however offset by decrease in ventricular work, hence the risk of myocardial ischaemia is not easy to defi ne.
We elected not to incorporate the variable of myocardial work into our study, as this would have added a signifi cant resource intensive complexity to the study, without necessarily adding further value to the results. This decision may be partially justifi ed by the observation that we did not fi nd a signifi cant difference in the Although care should be taken in transposing data from a porcine model to humans, our data suggest there is perhaps a direct pressure-fl ow relationship in IMA graft in humans. Practitioners should take cognisance of these relationships, and consider adjusting perfusion pressure to adequately increase the graft (and coronary) fl ow in order to meet myocardial demand. Naturally, the nature of a decrease in blood pressure should fi rst be defi ned. In addition, the practitioner should consider that a similar scenario exists for on-pump coronary grafting and also in the immediate postoperative period, although we did not specifi cally examine these hypotheses.
